Status:
COMPLETED
Moletest Clinical Study in Scotland
Lead Sponsor:
Moletest Scotland Ltd
Collaborating Sponsors:
Digital Health & Care Institute
NHS Lanarkshire
Conditions:
Melanoma
Eligibility:
All Genders
Brief Summary
To evaluate an iPad based photoimage analysis system (Moletest) for improving discrimination of benign from malignant suspicious skin lesions or moles. Specifically the objective is to demonstrate tha...
Eligibility Criteria
Inclusion
- All patients referred to the Dermatology Department, Lanarkshire Hospitals during a period to be defined for assessment of suspicious skin lesions (cutaneous moles) will be eligible for inclusion in the study. There are no age limits but patients under the age of 18 years will also have their inclusion subject to parental/guardian consent
Exclusion
- There is no exclsion criteria
Key Trial Info
Start Date :
March 27 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2017
Estimated Enrollment :
1120 Patients enrolled
Trial Details
Trial ID
NCT02196246
Start Date
March 27 2015
End Date
May 31 2017
Last Update
December 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NHS Lanarkshire R&D
Airdrie, United Kingdom, ML6 0JS